To investigate the efficacy of intralesional 20% aspirin injection for treatment of experimental peritoneal endometriosis.
Introduction
Endometriosis is an estrogen-dependent chronic inflammatory condition that affects an estimated 176 million women in reproductive age worldwide, and is associated with dysmenorrhea, deep dyspareunia, and infertility 1, 2 . Symptoms of endometriosis substantially contribute to disease burden and add substantial cost to society due to reduced economic and personal productivity 1, 2 .
Surgical removal of lesions and hormonal suppression are the current therapeutic gold standards for women with endometriosis-associated pelvic pain and/or infertility [1] [2] [3] . However, non-surgical intervention is mostly symptomatic, not cytoreductive and surgery is correlated with a high rate of recurrence with variable success and relapse rates according to the different reports [1] [2] [3] . Although lesion eradication is considered a fertilityenhancing procedure, benefits on reproductive performance are moderate [1] [2] [3] . As a consequence, established pharmacological or surgical approaches are not a feasible option for all patients within the wide clinical spectrum of endometriosis [1] [2] [3] .
In this context, emerging pharmacological therapies interfering with the inflammatory condition, hormone responsiveness, cell survival, proliferation, neoangiogenesis, and invasion have been mainly tested in preclinical studies, including . Thus, therapeutic research efforts should focus on identifying and testing welltolerated, low-cost, easily accessible substances capable of acting locally on lesions, without interfering with ovulation, for efficacy in both pain symptoms and infertility 6 .
Over the last decade, our research group [7] [8] [9] [10] [11] [12] Therefore, the present study assessed the therapeutic efficacy of intralesional 20% aspirin injection using the wellestablished peritoneal endometriosis rabbit model.
Methods
The experimental protocol was approved by the Research 
Animal housing and anesthesia
The study was performed as a parallel-group, doubleblind, stratified, randomized controlled animal trial with 1:1 allocation ratio. .
Induction of peritoneal endometriosis
Peritoneal endometriotic lesions were surgically induced, as previously described 
Treatment of endometriosis foci
At 30 postoperative days, when the endometriotic lesions had reached about 2.5 cm in diameter
12
, rabbits were randomly allocated using a computer generated process into experimental (n=20) and control (n=20) groups for a second laparotomy to receive intralesional injection of 20% aspirin or physiological saline solution, respectively. The 20% aspirin solution (pH 7.27) was obtained by diluting 2 g of acetylsalicylic acid (Pharma Nostra, Brazil) in 10 mL of 10% sodium bicarbonate solution. Treatments were administered as 0.2-0.4 mL aliquots of the experimental or control solution, as this volume was sufficient to infiltrate the entire peritoneal lesion 12 . The control and aspirin-treated groups were further sub-divided into equal groups for analysis of early (10 days posttreatment, n=10) and late (20 days post-treatment, n=10) effects. Thus, the four study groups were: control group 1 (10 days); control group 2 (20 days); aspirin-injected experimental group 3 (10 days); and aspirin-injected experimental group 4 (20 days). Animals were sacrificed by intravenous anesthesia overdose.
Clinical evolution
During the study period (variable according to group), clinical outcomes of all animals were assessed by objective parameters, including recovery from surgery, feeding behavior, and activity, being then classified into good, fair, or poor
11
.
Gross and microscopic analysis
Immediately upon anesthesia overdose, a third laparotomy was performed for measurement of the length and width in millimeters of each implant [12] [13] [14] [15] , evaluation of abdominal and thoracic cavities 11 , and specimen collection (all lesions were removed). Specimens were sectioned and stained with hematoxylin-eosin for histopathological analysis, which was conducted by an experienced pathologist who was blinded to the study. Qualitative analysis was performed by analyzing the histopathological characteristics (endometriosis level, necrosis, bleeding, inflammatory cells infiltrate and apoptosis) of surgical specimens 10, 16 . Quantitative analysis was performed by measuring the percentage of total endometriotic tissue represented by tumor cells using the Kontron KS300 V2.0 (Kontron AG, Eching/ München, Germany) imaging software, as previously reported
.
This computer program measures various shades within the blue, red, or green color spectrums. In the histological sections, endometrial tissue is colored in red; therefore the program, presents data as percent area colored in red, which is then analyzed to demonstrate the total area (in percentage) of endometriotic tissue 12 .
Statistical analysis
For the descriptive analysis, mean and standard deviations were used for metric variables, and percentages were given were considered significant at 95% confidence interval (p<0.05).
Results

Clinical evolution
All animals presented good clinical evolution in all three groups. No animal died during the experimental procedures.
Control group 1, 10 days post-treatment
Macroscopically, all implants formed cystic structures, 4 (40%) of which were hemorrhagic. This aspect was confirmed by microscopy, evidencing well-developed endometrial tissue cysts in all 10 (100%) samples.
Control group 2, 20 days post-treatment
Macroscopically, all implants formed cystic structures, half of which were hemorrhagic. This aspect was confirmed by microscopy, evidencing cystic formation (endometrial tissue cyst) in all 10 (100%) samples, with columnar epithelial lining associated with a stroma of fusiform cells. In 8 (80%) samples, the endometrium was in a proliferative phase; regions with numerous mitosis and a very small quantity of cellular apoptosis were observed, demonstrating that the endometrial tissue was growing freely in this phase (Figure 1 ). 
Aspirin-injected experimental group 3, 10 days post-treatment
All implants observed at the moment of re-operation had a hemorrhagic aspect and adherence to the endometrial cavity content, obstructing visual identification of the macroscopic 
Aspirin-injected experimental group 4, 20 days post-treatment
Macroscopically, implants of this group were also difficult to visualize, presenting adherence to the endometrial cavity content. Microscopy was unable to locate cystic formation of endometriosis or evidence of inflammatory process in any of the 10 (100%) analyzed samples, which presented only large areas of necrosis and apoptosis (Figure 3) . 
Gross and histological measurements
Inter-group comparisons of gross (total endometrial area) and histological (remaining viable endometrial tissue) measurements showed significant (p<0.05) differences (control groups 1 and 2 > experimental aspirin-treated group 3, 10 days post-treatment > experimental aspirin-treated group 4, 20 days post-treatment). The rest of the measurements revealed no intragroup significant (p>0.05) differences (control group 1 = control group 2) ( Table 1) . In this context, it is of paramount importance to acknowledge the definite need for the development of new drugs to provide specific and more efficient therapeutic alternatives to completely eliminate endometriotic lesions, prevent recurrences, and has none or low side effects 6 . Therefore, based on our previously tested different doses and periods of time in other experimental rabbit models [7] [8] [9] [10] [11] , the present study was delineated to evaluate whether a higher aspirin concentration and longer follow-up of outcomes (namely, 20% aspirin and 20 days after intralesional injection, respectively) could positively impact on completely reducing peritoneal endometrial tissue.
Our gross and histological results indicated that the effects of 20% aspirin injection on experimental group 3 (10 days) were similar to our previous study using 5% aspirin injection 12 , as there was only partial reduction of endometrial foci. However, results from experimental group 4 (20 days) showed a full response with 20% aspirin injection, evidenced by total elimination of gross and histological areas of endometriotic tissue, leaving only fibrosis, necrosis, and apoptosis in their place.
In addition, the mean gross and histological areas from aspirin-treated experimental group 4 (20 days) was significantly lower than the aspirin-treated experimental group 3 (10 days).
Data are presented as mean ± standard deviation; d, days after treatment; * p<0.0001 for all comparisons, except for Control group 1 vs Control group 2 with p>0.05
This particular result clearly demonstrates the maintenance and Another issue to consider is that it has been well demonstrated that there is an apoptotic dysregulation in the pathophysiology of endometriosis, although it is unlikely that apoptosis per se will explain the whole pathophysiology of endometriosis [29] [30] [31] . Thus, as it has been demonstrated that increased cell proliferation and decreased endometrial cell survival and apoptosis facilitate ectopic implantation of endometriotic cells in women with endometriosis [29] [30] [31] . Therefore, alternative therapies that induce apoptosis are relevant for the prevention and treatment of this disease. We demonstrated that aspirin-treated sample groups had a higher number of apoptotic cells compared to the control groups, and that there was a progressive increase in apoptosis among the experimental groups (10 days < 20 days).
Prior studies also showed increased apoptotic cells in different . Therefore, considering that COX-2 overexpression is a frequent finding in ectopic endometrium tissue [29] [30] [31] , we may assume that the direct injection of aspirin to endometriosis foci may stimulate apoptosis and destroy endometriotic cells (as observed in our experimental study) through a mechanism involving inhibition of COX proteins.
Future investigations are important to evaluate inhibition of COX proteins and COX-related pathways in endometriosis.
Potential limitations of our study should be addressed. We did not adopt all existing methods for assessment of histological outcomes, although our measurements were grounded in previously published methods [12] [13] [14] [15] . A further limitation is that our study focused solely on one therapeutic agent, and no comparisons were made with similar substances, such as acetic acid or other COX-2
inhibitors. In addition, we did not evaluate the pharmacological parameters (e.g., serum levels of study medication, possible systemic biochemical changes, and concentrations in peritoneal fluid) of the aspirin treatment. Since acetylsalicylic acid is one of the best studied therapeutic substances 23, 24 , we chose to focus our current study on its potential benefits as an intralesionallydelivered agent for peritoneal endometriosis. Further experimental studies should not only be designed to overcome these limitations but also to include additional long-term effects of aspirin treatment and different delivery methods (e.g., laparoscopic approach) prior to extending the analysis to humans in a clinical environment.
Conclusion
The rabbit model of peritoneal endometriosis was used to show that intralesional 20% aspirin injection does induce endometriosis destruction within 10 days after treatment, and that the anti-endometriotic effects were maintained and remained significant at 20 days post-injection, with progressive increase of apoptosis and with no signs of endometriotic tissue.
